Tag: patient advocacy mapping

In today’s pharmaceutical landscape, success isn’t defined by regulatory approval alone. The real challenge begins after market authorization — when companies must prove value, secure reimbursement, and reach patients faster. One major force reshaping this journey is Patient Engagement. Once considered a “nice-to-have,” it has become a strategic advantage that directly influences Market Access outcomes.…